Establishment of an Allo-Transplantable Hamster Cholangiocarcinoma Cell Line and Its Application for In Vivo Screening of Anti-Cancer Drugs

Opisthorchis viverrini (O. viverrini) is a well-known causative agent of cholangiocarcinoma (CCA) in humans. CCA is very resistant to chemotherapy and is frequently fatal. To understand the pathogenesis of CCA in humans, a rodent model was developed. However, the development of CCA in rodents is time-consuming and the xenograft-transplantation model of human CCA in immunodeficient mice is costly. Therefore, the establishment of an in vivo screening model for O. viverrini-associated CCA treatment was of interest. We developed a hamster CCA cell line, Ham-1, derived from the CCA tissue of O. viverrini-infected and N-nitrosodimethylamine-treated Syrian golden hamsters. Ham-1 has been maintained in Dulbecco's Modified Essential Medium supplemented with 10% fetal bovine serum for more than 30 subcultures. These cells are mostly diploid (2n=44) with some being polyploid. Tumorigenic properties of Ham-1 were demonstrated by allograft transplantation in hamsters. The transplanted tissues were highly proliferative and exhibited a glandular-like structure retaining a bile duct marker, cytokeratin 19. The usefulness of this for in vivo model was demonstrated by berberine treatment, a traditional medicine that is active against various cancers. Growth inhibitory effects of berberine, mainly by an induction of G1 cell cycle arrest, were observed in vitro and in vivo. In summary, we developed the allo-transplantable hamster CCA cell line, which can be used for chemotherapeutic drug testing in vitro and in vivo.

[1]  K. Sawanyawisuth,et al.  Clinical Manifestations of Eosinophilic Meningitis Due to Infection with Angiostrongylus cantonensis in Children , 2013, The Korean journal of parasitology.

[2]  T. Boonmars,et al.  A Cross-Sectional Study on Intestinal Parasitic Infections in Rural Communities, Northeast Thailand , 2013, The Korean journal of parasitology.

[3]  C. Wongkham,et al.  Chromosomes and karyotype analysis of a liver fluke, Opisthorchis viverrini, by scanning electron microscopy. , 2012, Parasitology international.

[4]  K. Sawanyawisuth,et al.  A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. , 2012, Parasitology international.

[5]  T. Boonmars,et al.  Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. , 2012, Parasitology international.

[6]  Jianping Chen,et al.  Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells. , 2012, Journal of pharmacological sciences.

[7]  Yoshiki Narimatsu,et al.  A novel serum carbohydrate marker on mucin 5AC , 2011, Cancer.

[8]  B. Aggarwal,et al.  Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation‐mediated molecular events related to multistep carcinogenesis , 2011, International journal of cancer.

[9]  S. Okada,et al.  Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF‐κB , 2010, Cancer science.

[10]  Hai-rim Shin,et al.  Epidemiology of cholangiocarcinoma: An update focusing on risk factors , 2010, Cancer science.

[11]  Y. Okabe,et al.  Surgery and chemotherapy for intrahepatic cholangiocarcinoma. , 2010, World journal of hepatology.

[12]  S. Tsao,et al.  Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. , 2009, Journal of ethnopharmacology.

[13]  T. Boonmars,et al.  Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma , 2009, Parasitology Research.

[14]  H. Hosseinzadeh,et al.  Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine , 2008, Phytotherapy research : PTR.

[15]  C. Pairojkul,et al.  Cholangiocarcinoma: lessons from Thailand , 2008, Current opinion in gastroenterology.

[16]  N. Khuntikeo,et al.  Urinary 8-Oxo-7,8-Dihydro-2′-Deoxyguanosine in Patients with Parasite Infection and Effect of Antiparasitic Drug in Relation to Cholangiocarcinogenesis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[17]  Yusuke Nakamura,et al.  Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma , 2006, Hepatology.

[18]  L. Cipak,et al.  Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. , 2006, Cancer letters.

[19]  S. Katiyar,et al.  Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells , 2006, Molecular Cancer Therapeutics.

[20]  J. Y. Liu,et al.  Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells , 2006, Archives of Toxicology.

[21]  C. Pairojkul,et al.  Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. , 2005, World journal of gastroenterology.

[22]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[23]  V. Reutrakul,et al.  Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. , 1998, Cancer letters.

[24]  S. Sirisinha,et al.  Establishment and characterization of cell lines from liver fluke-associated cholangiocarcinoma induced in a hamster model. , 1995, The Southeast Asian journal of tropical medicine and public health.

[25]  S. Lucas,et al.  Promotion of N-nitrosodimethylamine-initiated bile duct carcinogenesis in the hamster by the human liver fluke, Opisthorchis viverrini. , 1983, Carcinogenesis.

[26]  N. Bhamarapravati,et al.  Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. , 1978, Cancer research.